Please assess the completion status of the following clinical trial:

Trial Title: Assessing the Drug Exposure Risk of Infants Breastfed by Women With Inflammatory Bowel Disease

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_CONTROL
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Breastfeeding women with IBD or healthy breastfeeding women in the first 4-month postpartum period~Exclusion Criteria:~* unable to communicate in English~* Present illness of chronic inflammatory conditions (except IBD)~* Mastitis~* Present acute or chronic infection~* use of a different anti-TNFα drug within the last 2 months

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Women with IBD (Type: None): This group is composed of breastfeeding women aged over 18 years and in their first 4-month postpartum period, who are diagnosed with Crohn's disease or Ulcerative Colitis.
- Healthy breastfeeding women (Type: None): This group is composed of healthy breastfeeding women aged over 18 years and in their first 4-month postpartum period.

Based on this trial design, predict the completion outcome and termination type (if applicable).